Get started
Author

T. Tang

Observed names: T J Tang, T TANG, T Tang, T. J. Tang, T.J. Tang
ORCID: 0009-0002-7182-7809
Observed ORCID: 0009-0002-7182-7809
OpenAlex ID: A5013415442
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection
2003 · T. J. Tang, J. Kwekkeboom, et al. · Journal of Viral Hepatitis · 67
Effectiveness of endosponge therapy for the management of presacral abscesses following rectal surgery
2019 · J. F. Huisman, H. L. van Westreenen, et al. · Techniques in Coloproctology · 20
PDF
Endoscopic Resection Without Subsequent Ablation Therapy for Early Barrett’s Neoplasia: Endoscopic Findings and Long-Term Mortality
2020 · S.N. van Munster, E.A. Nieuwenhuis, et al. · Journal of Gastrointestinal Surgery · 19
PDF
Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study
2018 · Loes H C Nissen, Lauranne A A P Derikx, et al. · Inflammatory Bowel Diseases · 16
PDF
Monitoring intrahepatic CD8+ T cells by fine‐needle aspiration cytology in chronic hepatitis C infection
2004 · J. M. Vrolijk, T. J. Tang, et al. · Journal of Viral Hepatitis · 8
An approach to haemorrhoids
2005 · T. Tang, P. B. Lim, et al. · Colorectal Disease · 6
PDF
All-cause Mortality After Successful Endoscopic Eradication Therapy for Barrett’s Related Neoplasia in a Nationwide Cohort of 1154 Patients
2022 · E.P.D. Verheij, S.N. van Munster, et al. · Endoscopy · 4
Validation of the Charlson Comorbidity Index for prediction of mortality caused by other causes than esophageal adenocarcinoma after successful endoscopic eradication therapy for Barrett’s neoplasia
2023 · E.P. D. Verheij, S. N. Van Munster, et al. · Endoscopy
Limited risk of residual cancer after endoscopic resection of early Barrett’s neoplasia with confirmed vertical R1 margin: a nationwide cohort in the Netherlands
2023 · L. van Tilburg, E.P. D. Verheij, et al. · Endoscopy
Clinical relevance of random biopsies from the esophagogastric junction after complete eradication of Barrett’s esophagus is low
2023 · C. N. Frederiks, S. Van Munster, et al. · Endoscopy
The Natural Course of Untreated Neoplasia in Barrett’s Esophagus – a Case-series
2022 · E.P.D. Verheij, S.N. van Munster, et al. · Endoscopy
Poor Healing and Poor Squamous Regeneration after Radiofrequency Ablation Therapy for Early Barrett’s Neoplasia: Incidence, Risk Factors and Outcomes
2021 · SN van Munster, CN Frederiks, et al. · Endoscopy
Endoscopic Expert Revision of Previous Histological Confirmed Flat Low-Grade Dysplasia In Barrett’s Esophagus
2021 · EA Nieuwenhuis, SN van Munster, et al. · Endoscopy
DOP045 Predicting undesirable disease in newly diagnosed IBD patients – results from the Delta cohort
2014 · V. Nuij, G. Fuhler, et al. · Journal of Crohn s and Colitis
P177 Phenotype of inflammatory bowel disease at diagnosis in the Netherlands: a population-based inception cohort study (the DELTA cohort)
2013 · V. Nuij, Z. Zelinkova, et al. · Journal of Crohn s and Colitis
955 The predictive value of intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients
2003 · T TANG, R DEMAN, et al. · Hepatology
Works count: 16
Citation count: 140
H-index: 6
I10-index: 4
Year
Topic
Type